Skip to main content
Press release January 26, 2026

Kodak Expands Pharmaceuticals Portfolio with Four Regulated Products

Eastman Kodak Co (KODK)

New U.S. -Manufactured PBS and WFI Offerings Deliver Reliable, High-Quality Supply for Labs, Biopharma Industry and CDMOs ROCHESTER, N.Y. --(BUSINESS WIRE)--Jan. 26, 2026-- Eastman Kodak Company (NYSE: KODK) today announced the expansion of its pharmaceuticals portfolio with four new regulated
View original release